華檢醫療(01931.HK)獨董遭證監提研 不涉及公司業務
華檢醫療(01931.HK)公布,證監會周三(12日)公布中國網絡資本(00383.HK)及其六名前任及現任董事向市場失當行為審裁處提起研訊程序,原因是其沒有在合理切實可行的範圍內盡快披露內幕消息。公司獨立非執行董事劉紹基為中國網絡資本的一名前任獨立非執行董事,其向市場失當行為審裁處承認疏忽行為導致中國網絡資本違反企業披露制度的規定。
公司表示,由於市場失當行為審裁處作出的命令不涉及公司或其任何附屬公司,相關命令將不會對公司的業務或經營造成任何重大不利影響。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.